VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 237,264,020
- Share change
- +237,490
- Total reported value
- $68,520,934,164
- Put/Call ratio
- 91%
- Price per share
- $288.78
- Number of holders
- 1,206
- Value change
- +$69,172,686
- Number of buys
- 561
- Number of sells
- 494
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
9.9%
|
25,243,060
|
$7,308,875,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.3%
|
21,132,336
|
$6,118,657,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
6.8%
|
17,366,023
|
$5,028,159,000 | — | 30 Sep 2022 | |
| Capital World Investors |
13F
|
Company |
4.9%
|
12,524,679
|
$3,626,444,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.8%
|
12,294,791
|
$3,559,834,000 | — | 30 Sep 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.6%
|
9,145,516
|
$2,647,993,000 | — | 30 Sep 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
8,029,342
|
$2,324,815,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
5,271,667
|
$1,524,917,000 | — | 30 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2%
|
5,157,954
|
$1,493,458,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.9%
|
4,859,687
|
$1,407,074,000 | — | 30 Sep 2022 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.9%
|
4,755,821
|
$1,377,000,000 | — | 30 Sep 2022 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.7%
|
4,346,731
|
$1,258,552,000 | — | 30 Sep 2022 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.6%
|
4,158,390
|
$1,204,021,000 | — | 30 Sep 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.6%
|
4,041,993
|
$1,170,552,000 | — | 30 Sep 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.5%
|
3,900,856
|
$1,129,454,000 | — | 30 Sep 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
3,158,692
|
$914,567,681 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
2,887,998
|
$836,191,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.99%
|
2,527,455
|
$731,800,000 | — | 30 Sep 2022 | |
| NORGES BANK |
13F
|
Company |
0.9%
|
2,288,472
|
$662,604,183 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.84%
|
2,138,885
|
$619,293,000 | — | 30 Sep 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.84%
|
2,138,098
|
$619,065,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.82%
|
2,081,468
|
$602,669,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.76%
|
1,937,545
|
$560,996,000 | — | 30 Sep 2022 | |
| Amundi |
13F
|
Individual |
0.72%
|
1,825,322
|
$551,284,000 | — | 30 Sep 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.72%
|
1,827,457
|
$529,123,000 | — | 30 Sep 2022 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.71%
|
1,799,868
|
$521,134,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
1,720,747
|
$498,226,000 | — | 30 Sep 2022 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.64%
|
1,639,817
|
$474,793,000 | — | 30 Sep 2022 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.63%
|
1,605,854
|
$464,959,000 | — | 30 Sep 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.59%
|
1,501,535
|
$434,754,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
1,387,940
|
$401,864,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.52%
|
1,334,841
|
$386,490,000 | — | 30 Sep 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.52%
|
1,319,682
|
$382,097,000 | — | 30 Sep 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.49%
|
1,260,097
|
$364,849,000 | — | 30 Sep 2022 | |
| Bellevue Group AG |
13F
|
Company |
0.45%
|
1,158,126
|
$335,323,000 | — | 30 Sep 2022 | |
| Swiss National Bank |
13F
|
Company |
0.44%
|
1,108,375
|
$320,919,000 | — | 30 Sep 2022 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.43%
|
1,085,220
|
$314,215,000 | — | 30 Sep 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.37%
|
948,821
|
$274,721,632 | — | 30 Sep 2022 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.37%
|
936,055
|
$271,025,000 | — | 30 Sep 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.37%
|
932,851
|
$270,098,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.36%
|
923,240
|
$267,313,000 | — | 30 Sep 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.35%
|
897,308
|
$259,807,000 | — | 30 Sep 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.35%
|
880,754
|
$255,014,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.34%
|
864,307
|
$250,265,000 | — | 30 Sep 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.31%
|
782,783
|
$226,647,000 | — | 30 Sep 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.31%
|
778,271
|
$225,341,000 | — | 30 Sep 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.3%
|
751,883
|
$218,256,826 | — | 30 Sep 2022 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.28%
|
718,922
|
$208,225,000 | — | 30 Sep 2022 | |
| Impax Asset Management Group plc |
13F
|
Company |
0.27%
|
697,733
|
$201,646,000 | — | 30 Sep 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.26%
|
662,235
|
$191,744,000 | — | 30 Sep 2022 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2022
As of 31 Dec 2022,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,206 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
237,264,020 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Capital World Investors, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and JENNISON ASSOCIATES LLC.
This page lists
1,207
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
1,108
Q4 2022 holders
1,206
Holder diff
98
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.